Zymeworks presented data at the ESMO congress and was noted for its listing on Nasdaq amid AI stock competition.
4 reports, 3 independent
Updated Nov 9
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Zymeworks presented data at the ESMO congress and was noted for its listing on Nasdaq amid AI stock competition.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Citigroup and Jefferies reiterated buy/outperform ratings for Zymeworks.1 source
Zymeworks presented clinical data at ESMO and is competing in the AI stock market.1 source
Keep exploring
The entities involved
-
European Society for Medical Oncology
Professional organisation
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange